Abstract: The solar array (SA) serves as the sole energy source for satellites, continuously converting sunlight into electricity to power satellite operations. Sensors placed at key locations on the ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Journal Sentinel beat writers break down Wisconsin's win over Marquette The Journal Sentinel's John Steppe and Ben Steele discuss Wisconsin's 96-76 win over Marquette, which was UW's biggest win in ...

The Journal Sentinel's John Steppe and Ben Steele discuss Wisconsin's 96-76 win over Marquette, which was UW's biggest win in the rivalry since 1952. Where is the public betting in Week 15 of the NFL ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Journal Sentinel beat writers break down Wisconsin's win over Illinois The Journal Sentinel's Mark Stewart and John Steppe discuss some of their takeaways from the Badgers' 27-10 win over Illinois.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

The public can vote for the Milwaukee Journal Sentinel Athlete of the Week until 3 p.m. on Nov. 22. Nominees include swimmers Ella Antoniewski, Anne Dickinson, and Caroline Wanezek, diver Elsa ...